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Abstract A spontaneously restored sinus rhythm in per-
manent atrial fibrillation patients has been often observed
after mitral valve (MV) surgery, but persisting duration in
sinus rhythm varies from patient to patient. Heat shock
proteins (Hsps) may be involved in pathogenesis of atrial
fibrillation. We hypothesized that stabilization of restored
sinus rhythm is associated with expression of Hsps in the
atria. To test this hypothesis, clinical data, biopsies of right
atrial appendage, and blood samples were collected from
135 atrial fibrillation patients who spontaneously restored
sinus rhythm after conventional isolated MV replacement.
Comparison was made between patients who had recur-
rence of atrial fibrillation within 7 days (AF) vs. patients
with persisted sinus rhythm for more than 7 days (SR).
Results showed that SR patients had higher activity of heat
shock transcription factor 1 (HSF1) as well as upregulated
expressions of heat shock cognate 70, Hsp70, and Hsp27 in
the tissues. The activation of HSF1–Hsps pathway was
associated with less-aggressive pathogenesis as reflected by
lower rates of myolysis, apoptosis, interstitial fibrosis, and
inflammation in SR patients. However, Hsp60 was lower in
both tissue and plasma in SR patients, and was positively
correlated with apoptosis, interstitial fibrosis, and inflam-
mation. These findings suggest that the Hsps play important
roles in stabilization of restored sinus rhythm after MV
surgery by inhibiting AF-related atrial remodeling and
arrhythmogenic substrates in atrial fibrillation patients. Low
circulating Hsp60 levels preoperatively might predict a stable
spontaneously restored sinus rhythm postoperatively.
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Introduction
Atrial fibrillation (AF) is present in 40–60% of patients
undergoing mitral valve (MV) surgery (Raanani et al.
2001), and has been identified as a risk factor for poor
outcome after MV replacement (Ruel et al. 2005). Because
of limited success of electrical- and/or drug-induced
conversion, concomitant maze procedure and intraoperative
radiofrequency ablation have been used during the past two
decades (Raanani et al. 2001; Deneke et al. 2007).
However, it remains a significant concern for the inevitable
risk of perioperative complications and uncertainty regard-
ing atrial mechanical function (Cox et al. 2000; Boyd et al.
2009). In fact, most patients with chronic AF experience a
spontaneous restoration of sinus rhythm (SR) after MV
surgery. However, some patients could have a persistent SR
for a long period of time (from weeks to years), while
others might have recurrence of AF shortly after the surgery
(usually within 1 week; Chua et al. 1994; Large et al. 1997;
Jessurun et al. 2000). The spontaneous restoration of SR
may be attributed by an improved transmitral haemody-
namics after the surgery (Large et al. 1997; Raine et al.
2004), but the mechanism by which the patients have a
persisted SR remains unknown. Moreover, there are no
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Heat shock proteins (Hsps), a family of highly conserved
and stress-induced proteins, serve as molecular chaperones to
refold denatured proteins and promote the degradation of
damaged proteins via the activation and binding of heat shock
transcription factor 1 (HSF1) in many physiopathologic
processes (Parsell and Lindquist 1993; Sarge et al. 1993).
Recently, an elevated expression of Hsps in atrial tissue,
including isoforms of Hsp27, heat shock cognate (Hsc) 70,
and Hsp60, was found in AF patients (Y ang et al. 2007;
Brundel et al. 2006a;S c h ä f l e re ta l .2002), and higher atrial
levels of Hsp70 might be associated with a reduced risk of
postoperative AF (Mandal et al. 2005). It has also been
shown that induction of Hsps by hyperthermia and/or
geranylgeranylacetone could prevent the arrhythmogenic
substrates for AF (Takahashi et al. 2009; Brundel et al.
2006b). Conceivably, Hsps play an important role in the
pathogenesis and progression of AF.
In the present study, we tested our hypothesis that the
stabilization of spontaneously restored SR in patients with
permanent AF after MV surgery is associated with expres-
sions of Hsps in atria. To this end, we performed a study by
including 135 patients in order to obtain essential clinical data
as well as biopsies of right atrial appendages (RAAs) for
biochemical and histological analyses of HSF1 activity, Hsps
expression, myolysis, apoptosis, interstitial fibrosis, and
inflammation (Schotten et al. 2001; Aimé-Sempé et al.
1999; Burstein and Nattel 2008; Aviles et al. 2003). In
addition, Hsps levels in the serum were measured, presum-
ably to be used as a marker for AF recurrence.
Methods
Patients and study design
We consecutively recruited 135 patients admitted to the First
Affiliated Hospital of Nanjing Medical University between
November 2007 and June 2010. Inclusion criteria were: (1)
preoperative permanent AF (persisting at least 1 year; Obadia
et al. 1997) and (2) spontaneous restoration of SR after
conventional isolated MV replacement surgery. Exclusion
criteria were (1) history of cardiac arrhythmia other than AF;
(2) need of coronary artery bypass grafting (CABG) or other
associated procedures at the same time; (3) requirement of
redo surgery; (4) previous permanent pacemaker and/or
automatic implantable cardioverter defibrillator implantation;
(5) severe postoperative complications; and (6) requirement
of postoperative pacemaker implantation or treatment with
antiarrhythmic agent (except digitalis) within 7 days. The
present study was conducted according to the Helsinki
Declaration and approved by the ethics committee of
Nanjing Medical University. All the patients were given
written informed consent before being included in the study.
Surgery and tissue collection
The same cardiac anesthesiologist, perfusionist, and surgical
team performed all of these operations. All the patients
underwent standard cardiopulmonary bypass with moderate
hypothermia, antegrade crystalloid cardioplegic arrest, and
local hypothermia with ice slash. The MV was approached
through a transseptal approach and replaced with prosthetic
valves. The 135 patients returned spontaneously to SR when
they were weaned from extracorporeal circulation and
remained in SR to the end of surgical procedure.
About 250 mg RAA tissue for each patient was obtained
from the cannulation site before starting extracorporeal
circulation. Fifty milligram RAAs were fixed in paraformal-
dehyde for histology and immunohistochemistry, and the
others were immediately snap-frozen in liquid nitrogen for
biochemical analysis.
Recurrence of AF
After surgery, patients were transferred to the cardiothoracic
intensive care unit. The patients were monitored by continu-
ous electrocardiogram (ECG) during a minimum period of
48 h postoperatively; and afterwards, it was repeated at least
every 8 h for 15-min each time until discharge. In case of
rhythmdisturbancereportedbynurseorpatientintheinterval,
a 12-lead ECG recording was conducted and continuousECG
monitoring was reused. The recurrence of AF was diagnosed
onthebasisofaminimumof15-minAFdurationdocumented
by a continuous 12-lead ECG recording (Mariscalco and
Engström 2008). Before discharge, the patients were divided
into two groups according to whether (AF group) or not (SR
group) AF recurrence took place within 7 days postopera-
tively (Korantzopoulos et al. 2005).
Western blot
Frozen RAAs were used for protein isolation as described
previously (Brundel et al. 2006b). Proteins (40 μg/lane)
were separated by sodium dodecyl sulfate polyacrylamide
gel electropheresis and transferred onto polylinylidene
fluoride membranes using a Bio-Rad semidry transfer
system (Bio-Rad). The membranes were blocked with 5%
non-fat dry milk and then probed with horseradish peroxidase
(HRP)-conjugated mouse monoclonal anti-GAPDH (KC-
5 G5, KangChen Biotech, China), rabbit monoclonal anti-
cleaved caspase-3 (#9661, Cell Signaling Technology, USA),
rabbit polyoclonal anti-HSF1 (SPA-901), mouse monoclonal
anti-Hsc70 (ALX-804-067), mouse monoclonal anti-Hsp70
(SPA-810), goat polyoclonal anti-Hsp60 (SPA-828), or rabbit
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gies, Victoria, Canada). The working dilutions were 1:1,000
for all the primary antibodies. The resulting reaction was
visualized using HRP-conjugated anti-rabbit or anti-mouse or
anti-goatIgG secondary antibody(Santa-Cruz Biotechnology,
the Netherlands), followed by incubation with ECLWestern
Blot Detection Kit (Amersham, the Netherlands) for 1 min.
The blots were exposed to Kodak film for 5 min and
immunoreactive bands developed for quantification using
The Discovery Series™ image analysis software (Bio-Rad)
normalized by the corresponding value of GAPDH. Experi-
ments were repeated three times and the mean was scored.
Electrophoretic mobility shift assay
Preparation of nuclear extracts from RAAs and electropho-
retic mobility shift assay (EMSA) were done according to a
previous report (Metzler et al. 2003). Briefly, HSF1
binding activity in isolated nuclear protein was examined
by EMSA in a 20 μl of reaction mixture [1× binding
buffer, 50 ng/μl poly (dI·dC), 50% glycerol, 1% NP-40,
1MK C l ,1 0 0m MM g C l 2 ,1 5μg of nuclear proteins, and
40 fmol of
32P-labeled HSE consensus sequence oligonu-
cleotide (5′-CTAGAAGCTTCTAGAAGCTTCTAG-3′)].
The reaction mixture was incubated at room temperature
for 20 min and analyzed by electrophoresis on 6% non-
denaturing polyacrylamide gels. The gels were dried by
Gel-drier (Bio-Rad) and visualized by autoradiography.
The density of the binding bands was analyzed by the
Discovery Series™ image analysis software (Bio-Rad).
The level of activated HSF1 was calculated in relation to
the maximum value.
Histology and immunohistochemistry
After fixation with 4% paraformaldehyde in phosphate-
buffered saline (pH: 7.4) for 24 h, the tissues were subjected
to alcoholic dehydration and embedded in paraffin. Two
micrometer serial sections were sliced and subjected to V an
Gieson staining for microscopic examination. Collagen
volume fraction (CVF) was determined by the HPISA 100
chromatic color pathological analysis system using five
random images from each slide and five slides per sample,
and the mean values of CVF were obtained by one
investigator blinded to the groups.
To quantify the degree of myolysis, 2 μm-thick sections
were stained with periodic acid Schiff (PAS) and counter-
stained with toluidine blue (TB) and examined by light
microscopy. At least three sections per patient were examined
with a minimum of 200 cells in total. The degree of myolysis
was defined according to the percent of severe myolytic
myocytes by one investigator who was blinded to the study
groups,andmeanscoreswerecalculated(Schottenetal.2001).
Immunohistochemical staining for detecting HSF1,
Hsc70, Hsp70, Hsp60, or Hsp27 (the same antibodies as
Western blot but with working dilution at 1:100) was
performed on 4 μm-thick sections from each paraffin-
embedded tissues, according to a previous report elsewhere
(Mandal et al. 2005). A peroxidase-based detection system
was used, with diaminobenzidin as the final chromogen.
Terminal-deoxynucleotidyl transferase-mediated nick
end labeling
Apoptosis was examined by terminal-deoxynucleotidyl
transferase-mediated nick end labeling (TUNEL) method
(Aimé-Sempé et al. 1999). Four 4 μm-thick sections from
each block were evaluated for percentage of apoptotic cells
using a POD TUNEL kit (Roche). Four fields per section
were randomly examined using a defined rectangular field
area with magnification ×200. The number of TdT-labeled
cells was determined by counting at least 500 myocytes in
sections, and expressed as a percentage of the total number
of cells.
Immunofluorescent staining
Frozen sections were fixed for 10 min in 100% methanol (−20°
C), dried and blocked in 5% BSA (20 min room temperature).
Mouse monoclonal anti-myosin heavy chain (ab15, Abcam,
USA) and Hsp27 (the same antibody as immunohistochemis-
try) were used. The working dilutions were 1:100 for the both
primary antibodies. Fluorescein labeled isothiocyanate anti-
mouse (Jackson ImmunoResearch, The Netherlands) or N,N′-
(dipropyl)-tetramethyl-indocarbocyanine Cy3 anti-rabbit
(Amersham,TheNetherlands) was usedas secondaryantibody.
Nuclei were visualized by 4′,6-diamidino-2-phenylindole
staining.
Enzyme-linked immunosorbent assay
V enous blood samples were obtained in EDTA from each
patient before surgery. Plasma was separated and stored
at −80°C until analysis. The concentrations of myocardial
tissue interleukin (IL)-6 and tumor necrosis factor (TNF)-α
and plasma Hsps were measured by enzyme-linked immuno-
sorbent assay (ELISA; human TNF-α and IL-10 ELISA kits,
Biomed Diagnostics, Singapore; human Hsps ELISA kits,
StressGen Biotechnologies, Victoria, Canada), according to
the manufacturer’s instructions. Assays were performed in
triplicate in a single run and normalized to a standard curve.
Statistical analysis
For the comparison between the two groups, Student’s t test
(normally distributed) or Mann–Whitney test (non-normally
Hsps in stabilization of spontaneously restored sinus rhythm 519distributed) was used for continuous variables, and χ
2
test was utilized for categorical variables. Correlation
analysis (Pearson or Spearman) was used to assess the
association between atrial Hsps contents and histological
and biochemical results in RAAs and corresponding serum
Hsps levels. p<0.05 (two-sides) were used as the criterion
of statistical significance. Multiple logistic regression
analysis was performed to test whether any of the
preoperative parameters and plasma Hsps levels could
predict early recurrence of AF. All univariate variables
with p<0.1 were investigated in a multivariate model. In
the multivariate model, a variable was excluded when p≥
0.05. The statistical analysis was performed with the
GBSTA T statistical analysis package (version 9.0, Dy-
namic Microsystems, Inc).
Results
Patient characteristics
The 135 patients were divided into SR group (n=52) and
AF group (n=83). No significant differences were found in
terms of age and gender distribution. The preoperative
echocardiographic atrial sizes were smaller in SR than AF.
The preoperative plasma levels of C-reactive protein (CRP)
and central venous pressure were lower in SR than AF. In
addition, durations of staying at intensive care unit and
postoperative hospitalization were shorter in SR than AF
(Table 1).
Expression and activity of HSF1 in RAAs
Immunohistochemistry showed that the expression of HSF1
was comparable between AF and SR groups (Fig. 1a),
which was confirmed by Western blot analysis (Fig. 1b,c).
To determine whether the modified proportion of HSF1 was
larger in SR patients, a small amount of protein (20 μg/
lane) was loaded in 10% gel, which allows better separation
of proteins with moderate changes in molecular weight. As
shown in Fig. 1d, gray scale of the two HSF1 bands
appeared to shift to higher molecular weight species (Dimer
and Trimer) and were more intensive in SR than AF. EMSA
showed further that the activity of HSF1 was higher in SR
than AF (Fig. 1e,f).
Expression of Hsps in RAAs
Both immunohistochemistry and Western blot analysis
showed an increased expression of Hsc70 (1–3i n
Fig. 2a), Hsp70 (1–3 in Fig. 2b), and Hsp27 (1–3i n
Fig. 2d) and reduced expression of Hsp60 (1–3 in Fig. 2c)
in SR than AF. Hsc70 and Hsp70 immunoreactivities were
found in both cytoplasm and nucleus (1 in Fig. 2a,b),
whereas Hsp60 and Hsp27 were merely found in cytoplasm
(1 in Fig. 2c,d).
Myolysis, apoptosis, interstitial fibrosis, and inflammation
in RAAs
A degree of myolysis appeared in either AF or SR by PAS
and TB staining (Fig. 3a), but the percentage of cells with
severe myolysis was found to be lower in SR than AF
(Fig. 3b).
Apoptotic cells, revealed by TUNEL method, were less
numerous in SR than AF (Fig. 4a,c). Western blot analysis
showed further that cleaved caspase-3 protein levels were
also lower in SR than AF (Fig. 4b,d).
Interstitial collagen, revealed by V an Gieson staining and
expressed as CVF, was lower in SR than AF (Fig. 5a,b).
The levels of TNF-α and IL-6, determined by ELISA,
were lower in SR than AF (Fig. 6a,b).
Correlations between atrial Hsps levels and HSF1 activity,
myolysis, apoptosis, fibrosis and inflammation in RAAs
Taken these data together, correlation test revealed a
positive correlation between HSF1 activity and atrial
expressions of Hsc70, Hsp70 and Hsp27, but not Hsp60,
and a negative correlation between Hsp27 and myolysis
(Table 2). A partial co-localization of Hsp27 with myosin
was observed (Fig. 3c). Moreover, ratio of apoptotic cells,
cleaved caspase-3 levels and CVF were correlated posi-
tively with atrial Hsp60 contents and negatively with atrial
Hsc70, Hsp70, and Hsp27 contents. TNF-α and IL-6 levels
were correlated positively with atrial Hsp60 contents and
negatively with atrial Hsp70 levels. A weak but significant
negativecorrelationwas alsofound betweenTNF-α andatrial
Hsc70 contents (p=0.023; Table 2).
Correlations between plasma and atrial Hsps levels
Plasma levels of Hsc70, Hsp70, Hsp27, and Hsp60 in all
the samples were measured by ELISA, and only Hsp60
levels were lower in SR than AF (p<0.01; Fig. 7a; data not
shown regarding other Hsps). The correlation test indicated
a strong positive correlations between plasma and atrial
Hsp60 levels (r=0.557, p<0.001; Fig. 7b).
Preoperative variables predicting early recurrence of AF
The results of multiple logistic regression analysis are
shown in Table 3. Preoperative echocardiographic left
atrial diameter and plasma CRP and Hsp60 levels were
independent predictors of early recurrence of AF after
surgery.
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The present study confirmed that a large preoperative
echocardiographic left atrial size was an independent risk
factor for early recurrence of AF after MV surgery (Chua et
al. 1994; Large et al. 1997; Jessurun et al. 2000). In
addition, we also found preoperative higher plasma levels
of CRP and Hsp60 could predict early recurrence of AF.
More importantly, we further tested the hypothesis that the
stabilization of restored SR is associated with expression of
Hsps in the atria.
A study using an animal model of atherosclerotic lesions
showed that both mechanical stretching and treatment with
TNF-α resulted in activation of HSF1, which was associated
V ariables AF SR p value
Basic data
Patient number (n) 83 52 −
Gender, M/F (n) 36/47 18/34 0.312
Age (years) 48.8±10.2 49.0±9.4 0.921
Preoperative data
Heart rate (beats/min) 82±13 82±13 0.803
Mean artery pressure (mmHg) 91.7±11.3 90.2±8.8 0.858
C-reactive protein (mg/L) 5.80±2.40 3.65±1.96 <0.001
Duration of mitral disease (years) 9.4±4.1 9.4±3.7 0.806
Duration of AF (years) 2.6±1.5 2.6±1.5 0.953
NYHA class I/II/III/IV 3/29/34/17 2/16/31/3 0.067
Echocardiography
LVDd (mm) 52.9±8.2 51.3±9.6 0.116
LVDs (mm) 36.4±6.9 35.8±8.4 0.283
EF (%) 62.0±5.8 62.9±5.2 0.107
LAD (mm) 60.8±8.2 46.9±5.0 <0.001
RAD (mm) 46.3±5.9 41.4±3.7 <0.001
PASP (mmHg) 41.0±7.6 38.9±9.4 0.143
Mitral valve disease (n) 0.144
Pure mitral stenosis 44 28
Pure mitral regurgitation 10 12
Mitral stenoregurgitation 29 12
Cause of mitral valve disease (n) 0.121
Rheumatic 76 43
Degenerative 7 9
Preoperative length of stay (days) 14.2±6.0 14.8±4.4 0.297
Preoperative antiarrhythmics (n)
Digitalis 77 42 0.036
Calcium-channel blocker 13 3 0.084
Beta-blocker 30 12 0.110
ACE-I 24 12 0.455
Operative data
Central venous pressure (cmH2O) 5.1±1.5 4.3±1.3 <0.001
Combined TAP (n) 56 32 0.481
Left atrial thrombus (n) 22 9 0.216
CPB duration (min) 97±11 97±9 0.901
Aortic clamp time (min) 56±9 55±7 0.504
Postoperative data
Duration of ventilation (h) 23.0±6.0 22.5±7.4 0.315
Intensive care unit stay (h) 39.7±11.9 35.8±10.4 0.036
Postoperative length of stay (days) 17.1±3.2 14.0±2.5 <0.001
Table 1 Clinical characteristics
of study population
V alues are presented as mean±
SD or number of patients.
ACE-I angiotensin-converting
enzyme inhibitor, CPB cardio-
pulmonary bypass, EF ejection
fraction, LAD left atrial diame-
ter, LVDd left ventricular end-
diastolic diameter, LVDs left
ventricular end-systolic diame-
ter, NYHA New York Heart
Association, PASP pulmonary
artery systolic pressure, RAD
right atrial diameter, TAP tricus-
pid valve annuloplasty
Hsps in stabilization of spontaneously restored sinus rhythm 521with increased Hsps production in the aortas (Metzler et al.
2003). By a combination of genome-wide computational and
experimental methods, promoters of Hsps (including Hsp70,
Hsc70, Hsp27) are bound by HSF1 (Trinklein et al. 2004). In
patients with AF, a higher atrial Hsp70 expression was
associated with a lower incidence of postoperative AF
(Mandal et al. 2005), and the expressions of Hsc70 and
especially Hsp27 in atrial tissues were found to be higher in
paroxysmal AF than in persistent AF and SR patients (Y ang
et al. 2007; Brundel et al. 2006a). Hsp60, which has been
recently found the role in inhibiting arrhythmogenic atrial
remodeling (De Souza et al. 2010), was reported to be
elevated expression in atrial tissues of chronic AF patients in
comparison with SR patients (Schäfler et al. 2002). In the
present study, we investigated the expression and activity of
HSF1 as well as all these Hsps isoforms simultaneously in
135 patients (AF vs. SR). As expected, activation of HSF1
was associated with increased expression of Hsc70, Hsp70
and Hsp27 in SR patients. However, the expression of Hsp60
was unexpectedly reduced and not correlated with the
activity of HSF1 in these patients. A study using a rat model
of heart failure showed an increased binding of NF-кBb u t
not HSF1 to the binding elements of Hsp60 gene, suggesting
that Hsp60 might be not bound by HSF1 (Wang et al. 2010).
Moreover, studies using HSF1 knock-out and siRNA-HSF1
mice showed that Hsp60 was unlikely to play an important
role in maintaining redox-state, oxidative damage after
ischemia-reperfusion (Y an et al. 2002; Yin et al. 2005).
Conceivably, the Hsp60 expression is under control by other
mechanism rather than HSF1.
Recurrence of AF after cardioversion is likely related to
a biologic phenomenon known as remodeling, in which the
structural properties of atrial tissue and cardiac cells are
progressively and irreversibly altered, creating more favor-
able substrates for AF (Schotten et al. 2001; Aimé-Sempé
et al. 1999; Burstein and Nattel 2008; Aviles et al. 2003). In
the present study, we next examined the parameters
regarding myolysis, apoptosis, interstitial fibrosis, and
inflammation, in which Hsps are known to be involved in
general. In our SR patients, the rates of myolysis, apoptosis,
interstitial fibrosis, and inflammation in RAAs were lower
than that in the AF patients, which were negatively
correlated with the expressions of Hsps (i.e., Hsp70,
Hsc70, Hsp27) in RAAs. Recently, it was suggested that
Fig. 1 Expression and activity of heat-shock transcription factor 1
(HSF1) in right atrial appendages (RAAs). a Representative immu-
nostaining photomicrographs of HSF1 (×200, bar 50 μm). Note:
numerous stained nuclei (red arrows)i nS R( right photo). b, c
Western blot analysis of atrial HSF1 content. d Western immunoblots
of HSF1, separated by 10% gel with 20 μg protein/lane. Note: high
dense bands of trimer and dimer in SR. e, f Electrophoretic mobility
shift assay of HSE-binding activity of HSF1. NS nonspecific complex.
In c and f, values are expressed as mean±SEM; **p<0.01; NS not
significant

522 H. Cao et al.Fig. 2 Expression and localization of heat shock proteins (Hsps) in
RAAs: a Hsc70, b Hsp70, c Hsp60, and d Hsp27; 1 representative
immunostaining photomicrographs of AF and SR (×200, bar 50 μm);
2 and 3 Western blot analysis. V alues are expressed as mean±SEM;
**p<0.01
Hsps in stabilization of spontaneously restored sinus rhythm 523overexpression of Hsp27 could protect against tachypacing-
induced myolysis in a cell model of AF (Brundel et al.
2006a). Indeed, we found that Hsp27 was localized to
myofibrils and it was elevated in SR patients.
Sustained AF induces cardiomyocyte apoptosis and
fibrosis in the atria, which may promote AF recurrence
after surgery (Aimé-Sempé et al. 1999; Burstein and Nattel
2008). The apoptosis and fibrosis could be attenuated by
activation of HSF1 in the heart, as shown in a study using
HSF1 transgenic mice (Sakamoto et al. 2006). Indeed,
accumulated evidence indicates that the Hsps act directly
on the cell death machinery and signaling pathway for cell
death (Sreedhar and Csermely 2004). In the present study,
we found that the high binding activity of HSF1 and the
Fig. 3 Myolysis in RAAs and localization of Hsp27 in atrial
myofibrils. a Representative photomicrographs showing less loss of
sarcomeres (blue staining) and accumulation of glycogen (red
staining) in SR (red arrows, ×400, bar 20 μm). b The degree of
myolysis, expressed as mean±SEM; **p<0.01. c Representative
immunofluorescent photomicrographs of longitudinal (AF) and trans-
verse (SR) sections showing myosin (green), Hsp27 (red), nuclei
(DAPI, blue) and co-localization of Hsp27 with myosin (yellow)i n
RAAs (×200, bar 50 μm)
Fig. 4 Apoptosis in RAAs. a Representative photomicrographs of
TUNEL staining (red arrows, ×200, bar 50 μm). b Representative
Western immunoblots of cleaved caspase-3 and GAPDH. c Apoptosis
ratios and d atrial cleaved caspase-3 content are expressed as mean±
SEM; **p<0.01
Fig. 5 Fibrosis in RAAs. a Representative photomicrographs of V an
Gieson staining showing the interstitial collagen (red) (×200, bar
50 μm). b Collagen volume fraction is expressed as mean±SEM;
**p<0.01
524 H. Cao et al.increasedexpressionsofHsc70,Hsp70,andHsp27intheatria
were associated with the reduced number of apoptotic cells as
well as levels of cleaved caspase-3 in SR patients, suggesting
that the reduced caspase-3-mediated apoptosis by the activa-
tion of HSF1–Hsps pathway may attribute to the stabilization
of restored SR. Furthermore, Hsps, especially Hsp70, Hsp27
and Hsc70, have been shown to exhibit anti-fibrotic effects
(Takahashi et al. 2009; Wakisaka et al. 2007; Zou et al. 2008;
Chen et al. 2004). In the present study, we found that the
same HSF1–Hsps pathway of fibrosis as the apoptosis may
also play a role in stabilization of restored SR.
Inflammation has been suggested to play an important role
in atrial remodeling, which encourages the propensity to
relapse into AF after cardioversion (Aviles et al. 2003;
Korantzopoulos et al. 2005; Dernellis and Panaretou 2004).
The expression of Hsp70 is elevated in response to
inflammation (Chen et al. 2004), and moderate hyperthermia
during cardiopulmonary bypass could attenuate the inflam-
matory response by inducing expression of Hsp70 (Hayashi
et al. 2002). Pretreatment with Hsc70 both in vitro and in
Correlation coefficient
Hsc70 Hsp70 Hsp60 Hsp27
HSF1 activity 0.620
** 0.766
** −0.211 0.650
**
Degree of myolysis −0.073 −0.114 0.204 −0.512
**
Ratio of apoptotic cell −0.634
** −0.758
** 0.537
** −0.420
**
Cleaved caspase-3 −0.741
** −0.890
** 0.655
** −0.569
**
CVF −0.607
** −0.732
** 0.467
** −0.528
**
TNF-α −0.322
* −0.416
** 0.612
** −0.220
IL-6 −0.218 −0.403
** 0.582
** −0.177
Table 2 Correlations between
atrial Hsps levels and HSF1
activity, myolysis, apoptosis,
interstitial fibrosis and inflam-
mation in RAAs
CVF collagen volume fraction
*p<0.05, **p<0.01
Fig. 7 Correlation between plasma levels and atrial contents of
Hsp60. a Box plots illustrating median plasma levels of Hsp60 in AF
and SR. Boxes interquartile ranges, bars 10th and 90th percentiles.
**p<0.01. b Correlation test
Fig. 6 Inflammation in RAAs. a TNF-α and b IL-6 levels are
expressed as mean±SEM; **p<0.01
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(Zou et al. 2008;S ue ta l .2010). In the present study,
reduced levels of TNF-α and IL-6 in the atrial tissue of SR
patients were found, which was in line with the report
showing elevated levels of TNF-α and IL-6 in AF patients
(Qu et al. 2009).
Unlike other Hsps, Hsp60 expression was found to be
positively correlated with apoptosis, interstitial fibrosis and
inflammation in RAAs. A recent study in cardiac myocytes
showed that Hsp60 activated Toll-like receptor 4, leading to
cytokine productionand myocyte apoptosis (Kim etal. 2009).
A study in human myocardial specimens with heart failure
showed also that Hsp60 was positively correlated with
apoptosis (Lin et al. 2007). It is known that TNF-α increases
the myocyte apoptosis as well as Hsp60 expression, probably
by activation of NF-κB and that Hsp60 contains NF-кB
binding elements (Kim et al. 2009). In a study with rat model
of heart failure, an increased binding of NF-кBt ob o t h
binding elements of Hsp60 gene was suggested to be
associated with enhanced levels of inflammatory factors
(Wang et al. 2010). Furthermore, in a cardiac cell line, TNF-
α treatment increased the Hsp60 expression, which could be
prevented by pretreatment with siRNA inhibiting p65
expression (Wang et al. 2010). Taken together, we may
suggest that reduced expression of Hsp60 in SR patients is
partly associated with reduced rate of apoptosis and resultant
interstitial fibrosis and digression of inflammation. We
therefore propose that autologous Hsp60 may serve as a
deleterious agent for the stabilization of restored SR.
Hsps have been considered to function intracellularly
(Parsell and Lindquist 1993;M a n d a le ta l .2005;B r u n d e le t
al. 2006b). Recently, it has been suggested that these proteins
can also be released from cells and present in the peripheral
blood (Pockley et al. 2003; Zhang et al. 2008). According to
previous studies, increased preoperative plasma anti-Hsp60
IgG levels and enhanced pre- and postoperative circulating
Hsp70 levels in patients undergoing CABG were associated
with the occurrence of postoperative AF (Oc et al. 2007,
2008). The mechanisms were considered to the possible role
of Hsps in inflammation and cross-reactive autoimmunity
during the development of AF. In contrast, Mandal et al.
observed that high intracellular, but not circulating Hsp70
was associated with postoperative AF, and they also failed to
identify a correlation between atrial Hsp70 content and
serum-soluble Hsp70 level (Mandal et al. 2005). In the
present study, we found, for the first time, plasma Hsp60
levels, but not Hsc70, Hsp70, and Hsp27, could reflect its
atrial contents and could predict early recurrence of AF
independently. Therefore, we suggest that the determination
of plasma levels of Hsp60 before surgery could be used to
predict the stabilization of restored SR after the surgery.
Potential clinical perspective
Activation of HSF1-Hsps pathway by hyperthermia and/or
geranylgeranylacetone may prevent the arrhythmogenic sub-
strates for AF (Takahashi et al. 2009; Brundel et al. 2006b).
Because the stabilization of restored SR after MV surgery is
associated with activation of Hsp70, Hsp27, and Hsc70,
interventions that stimulate these proteins may prevent the
atrial remodeling that leads to AF development and
recurrence, thereby affording a new possible therapeutic
modality in managing this common complication.
Although successful restoration of SR has been identified
to increase quality of life and survival (Raanani et al. 2001;
Deneke et al. 2007), the results of surgical cardioversion
were controversial in MV patients with permanent AF (Chua
et al. 1994; Large et al. 1997; Jessurun et al. 2000; Raine et
al. 2004). The patients with early recurrence of AF have
more advanced pathological changes in the atria and may be
good candidates for concomitant anti-AF procedures. There-
fore, it is valuable in predicting which patients in AF
undergoing MV surgery are prone to having the early
recurrence of AF postoperatively. According to the present
study, we may suggest that the patients with larger
preoperative echocardiographic left atrial sizes, higher
preoperative plasma levels of CRP and especially Hsp60
are more likely to develop an early recurrence and are
suitable for a concomitant surgical cardioversion.
Study limitations
First,wecouldnotexcludethepatientswhohadasymptomatic
recurrences of AF for more than 15 min but spontaneously
restored SR in the interval of 12-lead ECG monitoring at least
every 8 h. Therefore, it was possible that some asymptomatic
early recurrence occur. Second, owing to a lack of information
regarding left atria, it is unknown if the left atria could be a
more ideal material in the patients studied, thus further
evaluation is warranted. Third, the underlying mechanisms of
the reduction of Hsp60 in both tissue and circulation in SR
patients need to be elucidated in future studies. Finally, a large
Table 3 Preoperative predictors of AF early recurrence in multivar-
iate logistic regression analysis
V ariables B 95%CI p value
C reactive protein −0.043 −0.067 to −0.018 0.001
LAD −0.029 −0.035 to −0.023 <0.001
RAD −0.005 −0.017 to 0.008 0.445
NYHA class 0.025 −0.054 to 0.104 0.538
Central venous pressure 0.013 −0.031 to 0.057 0.564
Plasma Hsp60 −0.007 −0.012 to −0.002 0.006
B regression coefficient, CI confidence interval; other abbreviations as
in Table 1
526 H. Cao et al.prospective case–control trial is warranted to calculate the
sensitivity, specificity, and predictive values of circulating
Hsp60.
Conclusions
A significant activation of HSF1 and resultant accumulation
of Hsc70, Hsp70, and Hsp27 in atrial tissues may prevent the
recurrence of AF in patients after conventional isolated MV
replacement. It is likely that these Hsps could stabilize the
restored SR by inhibiting AF-related atrial remodeling and
substrates of pathogenesis. Exceptionally, Hsp60 might play
adverse roles in those patients. Preoperative low circulating
Hsp60 levels may indicate a stable SR postoperatively.
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